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Tubular overexpression  
of transforming growth factor-β1 
induces autophagy and fibrosis  
but not mesenchymal transition  
of renal epithelial cells
Koesters et al., Am J Pathol 2010; 177: 632–643; doi:10.2353/
ajpath.2010.091012
Transforming growth factor-β (TGF-β) is considered to play a 
major role in the fibrosis that contributes to progression of chronic 
renal failure. TGF-β1 is thought to trigger several mechanisms 
that lead to fibrosis, among them activation of resident fibroblasts 
and stimulation of tubular epithelial cells to transform into mes-
enchymal cells, which would contribute as myofibroblasts to the 
interstitial fibrosis in a process labeled epithelial-to-mesenchymal 
transition (EMT). The significance of EMT for the development of 
fibrosis in chronic renal disease remains a matter of controversy. 
Koesters et al. analyzed the role of overexpression of TGF-β by 
tubular epithelial cells in the generation of fibrosis and the cells 
involved, by using mice with inducible TGF-β overexpression in 
proximal tubular cells. The initial response to tubular cell-derived 
TGF-β1 consisted of a robust proliferation of peritubular cells and 
deposition of collagen. On sustained TGF-β expression, nephrons 
degenerated in a focal pattern with tubular dedifferentiation and 
decomposition of tubular cells by autophagy. Thus, TGF-β1 may 
drive autophagy in tubular epithelial cells, which may represent a 
novel mechanism of tubular atrophy. The interstitial fibrosis resulted 
from myofibroblasts that were derived from local fibroblasts. Nei-
ther tracing of injured tubules in electron micrographs nor genetic 
tagging of tubular epithelial cells revealed cells transgressing the 
tubular basement membrane.
Thus, the authors found no evidence of a transition of tubular 
cells into myofibroblasts, nor for migration of tubular cells into 
the interstitium. They conclude that while overexpression of TGF-
β1 in renal tubules in vivo induces tubular atrophy with marked 
autophagy and interstitial fibrosis, this does not involve the genera-
tion of myofibroblasts through EMT.
Detlef Schlöndorff
Activation of vascular smooth 
muscle parathyroid hormone 
receptor inhibits WNT/β-catenin 
signaling and aortic fibrosis in 
diabetic arteriosclerosis
Cheng et al., Circ Res 2010; 107: 271–282; doi:10.1161/CIRCRESAHA.110.219899
Arteriosclerotic fibrosis and calcification of conduit vessels com-
promise smooth distal tissue perfusion, increasing the risk of lower 
extremity amputation. Arteriosclerosis is an actively regulated 
process potentiated in part via oxidative stress and osteogenic 
wingless-type integration site family member (Wnt)/β-catenin 
signaling. Parathyroid hormone 1 receptor (PTH1R) is expressed 
in bone and vascular smooth muscle, and intermittent parathyroid 
hormone (PTH) administration stimulates bone formation but sup-
presses arterial calcification. In order to determine the impact of 
vascular PTH1R activity on arteriosclerotic Wnt/β-catenin signaling 
in vitro and in vivo, Cheng and colleagues generated SM-caPTH1R 
transgenic mice, a model in which the constitutively active PTH1R 
variant H223R (caPTH1R) is expressed only in the vasculature. They 
found that the caPTH1R inhibited Wnt/β-catenin signaling, colla-
gen production, and vascular smooth muscle cell (VSMC) prolifera-
tion and calcification in vitro. Transgenic SM-caPTH1R;low-density 
lipoprotein receptor (LDLR)+/– mice fed high-fat diabetogenic diets 
develop diabesity, with no improvements in fasting serum glucose, 
cholesterol, weight, body composition, or bone mass as compared 
with LDLR+/– siblings. SM-caPTH1R downregulated aortic Col1A1, 
Runx2, and Nox1 expression without altering TNF, Msx2, Wnt7a/b, 
or Nox4. The SM-caPTH1R transgene decreased aortic β-catenin 
protein accumulation and signaling in diabetic LDLR+/– mice. 
Levels of aortic superoxide (a precursor of peroxide that activates 
pro-matrix metalloproteinase 9 and osteogenic signaling in VSMCs) 
were suppressed by the SM-caPTH1R transgene (Figure). Aortic 
calcification, collagen accumulation, and wall thickness were con-
comitantly reduced, enhancing vessel distensibility.
The authors conclude that procalcific and pro-osteogenic Wnt/β-
catenin signaling cascades are inhibited in VSMCs by cell-auton-
omous PTH receptor actions that reduce β-catenin signaling and 
vascular oxidative stress. It remains to be determined whether this 
very interesting finding of VSMC-autonomous PTH1R signaling 
has any (protective?) impact on vascular calcification with uremia. 
Furthermore, although increased aortic distensibility was observed 
ex vivo, improvements in vascular compliance in response to VSMC 
SM-caPTH1R transgene reduces aortic oxidative stress. (a) Aortic superoxide 
levels were reduced in LDLR+/– mice possessing the SM-caPTH1R transgene 
(n = 4 per group). (b) Pro-matrix metalloproteinase 9 (pro-MMP9) activity, an 
index of reactive oxygen species signaling downstream of tumor necrosis 
factor and aortic osteopontin 23, was reduced in VSMCs from LDLR+/– mice 
possessing the SM-caPTH1R transgene. Representative zymogram (left) and 
quantitative digital image analysis (right).
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PTH1R actions have yet to be demonstrated in vivo, and reduc-
tions in vascular reactive oxygen species may potentially improve 
endothelium-dependent vasodilatation. Because systemic PTH 
(1–34) administration reduces adventitial Msx2 and Wnt7,1 PTH1R 
signaling beyond medial VSMCs may play even more important 
roles in the regulation of vascular calcification.
Marc De Broe
1J Clin Invest 2005; 115: 1210–1220.
Racial variation in medical outcomes 
among living kidney donors
Lentine et al., N Engl J Med 2010; 363: 724–732
The waiting list for kidney transplants continues to grow, and the 
occurrence of deaths on the waiting list is far too common. Liv-
ing related donation offers far better outcomes for recipients than 
transplantation from the deceased-donor list. Thus, it is logical 
to increase the frequency of living-related-donor transplantation 
among those eligible for a kidney transplant, while remaining 
mindful that, for the donor, the rule of ‘first, do no harm’ applies. 
Lentine and colleagues’ large, retrospective observational cohort 
study of living donors linked donors to their subsequent billing 
records and examined by race the incidence of new diagnoses 
of hypertension, diabetes mellitus (DM), cardiovascular disease, 
and chronic kidney disease (CKD), as well as death, comparing 
these risks with expected rates within race for people participat-
ing in the National Health and Nutrition Examination Survey 
(NHANES). Donors were included if they had an Organ Procure-
ment and Transplantation Network record of being a living donor 
from October 1987 through July 2007 and were eligible for benefits 
under a single large national private US insurer participating in 
this study. Billing data from this health insurance provider were 
used to establish the medical diagnoses. Median follow-up time 
was 7.7 years following donation. As compared with non-Hispanic 
whites, both non-Hispanic black and Hispanic donors had a greater 
hazard of new hypertension, DM, and CKD following donation. 
This increased risk for all three events among non-Hispanic black 
donors was also seen in black as compared with white participants 
in the NHANES study. Among Hispanics, the increased risk for 
DM and CKD as compared with that of non-Hispanic whites was 
also seen in NHANES data. In the NHANES study, Hispanics had 
a lower chance of having hyper tension than whites.
The clinical message is simple and important. Previous studies 
demonstrate that the risk of these events following donation is low. 
However, the minority donor is at greater risk than the white donor 
of developing comorbid conditions. Thus, minority donors should 
know that risk is not absent, and that they are not protected from 
the greater burden of kidney disease that is felt within the black 
and Hispanic communities. These data remind us that increased 
vigilance regarding the development of CKD should be maintained 
throughout the lives of donors, and that risk assessment practices 
should be continued even after the declaration of health that justifies 
the ability to donate.
Lynda Szczech
Tissue kallikrein regulates renal 
excretion of potassium after a meal
El Moghrabi et al., Proc Natl Acad Sci USA 2010; 107: 13526–13531; doi:10.1073/
pnas.0913070107
Extracellular K+ concentration is maintained within a relatively wide 
range, since fasting and postprandial concentrations can vary sub-
stantially. Unlike the K+ content of the cellular compartment, that of 
the extracellular volume is very low, and, as K+ is rapidly absorbed 
by the digestive tract, the amount of K+ in a single meal represents a 
massive and rapid influx of K+ into the extracellular fluid. This would 
have a major impact on plasma [K+] in the absence of the rapid entry 
of extracellular K+ into cells, mainly under the influence of insulin. 
Needless to say, the long-term regulation of K+ balance is dependent 
on renal potassium excretion, which occurs mainly in the collect-
ing duct and is under the regulation of aldosterone, which activates 
K+ secretion. In conditions in which K+ needs to be retained, the 
collecting duct epithelium absorbs K+ by an apical electroneutral 
H+,K+-ATPase, but the contribution of this enzyme to K+ balance is 
still poorly understood. While most ingested K+ is disposed into the 
intracellular space, renal K+ excretion also contributes to the acute 
response to a K+ load, and it appears to do so independently of aldos-
terone. El Moghrabi et al. noted that K+ intake increases the renal 
excretion of tissue kallikrein (TK), and they examined the potential 
contribution of this serine protease to the aldosterone-independent 
renal K+ excretion. TK is abundant in the kidney, and serine pro-
teases are well-known regulators of renal ion channels. In wild-type 
mice, the authors found that after a single meal, representing an 
acute K+ load, renal K+ and TK excretion increased in parallel, while 
aldosterone secretion did not change. By using aldosterone synthase-
deficient mice, they confirmed that the control of TK secretion was 
aldosterone-independent. To test the role of TK in plasma K+ con-
centration, they used mice with TK gene disruption (TK−/−). A single 
large feeding did not lead to any significant change in plasma [K+] 
in TK+/+ mice, but TK−/− mice became hyperkalemic (Figure). The 
authors next examined the impact of TK disruption on K+ trans-
port in isolated cortical collecting ducts (CCDs) microperfused in 
vitro. They found that CCDs isolated from TK−/− mice exhibit net 
transepithelial K+ absorption because of abnormal activation of 
the H+,K+-ATPase. Finally, in CCDs isolated from TK−/− mice and 
microperfused in vitro, the addition of TK to the perfusate, but not 
to the peritubular bath, caused a 70% inhibition of H+,K+-ATPase 
activity. The study thus identifies the serine protease TK as a kaliu-
retic factor that participates in the protection against hyperkalemia 
after a dietary K+ load.
Juan Oliver
Effects of TK disruption on blood K+ concentration. K+ concentration in 
TK+/+ and TK−/− littermate mice in fasting and postprandial states.
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